COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine.
作者信息
Polosa Riccardo, Caci Grazia
机构信息
Dipartimento di Medicina Clinica e Sperimentale (MEDCLIN), University of Catania, Catania, Italy.
Center of Excellence for the Acceleration of HArm Reduction (CoEHAR), University of Catania, Catania, Italy.
出版信息
Intern Emerg Med. 2020 Aug;15(5):853-856. doi: 10.1007/s11739-020-02361-9. Epub 2020 May 19.
Abstract
摘要
相似文献
1
COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine.新型冠状病毒肺炎：吸烟流行率的反直觉数据及尼古丁的治疗意义
Intern Emerg Med. 2020 Aug;15(5):853-856. doi: 10.1007/s11739-020-02361-9. Epub 2020 May 19.
2
Systematic review of the prevalence of current smoking among hospitalized COVID‑19 patients in China: could nicotine be a therapeutic option?中国住院 COVID-19 患者当前吸烟率的系统评价：尼古丁能否成为一种治疗选择？
Intern Emerg Med. 2020 Nov;15(8):1601-1603. doi: 10.1007/s11739-020-02473-2. Epub 2020 Aug 16.
3
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?系统评价中国住院 COVID-19 患者中当前吸烟的流行率：尼古丁是否可以成为一种治疗选择？
Intern Emerg Med. 2020 Aug;15(5):845-852. doi: 10.1007/s11739-020-02355-7. Epub 2020 May 9.
4
COVID-19 and smoking: is nicotine the hidden link?新型冠状病毒肺炎与吸烟：尼古丁是隐藏的关联吗？
Eur Respir J. 2020 Jun 4;55(6). doi: 10.1183/13993003.01116-2020. Print 2020 Jun.
5
Beyond Smoking Cessation: Investigating Medicinal Nicotine to Prevent and Treat COVID-19.超越戒烟：研究药用尼古丁预防和治疗新冠病毒疾病
Nicotine Tob Res. 2020 Aug 24;22(9):1669-1670. doi: 10.1093/ntr/ntaa077.
6
[COVID-19 and changes in smoking behavior].[新型冠状病毒肺炎与吸烟行为的变化]
Rev Mal Respir. 2020 Oct;37(8):684-686. doi: 10.1016/j.rmr.2020.08.004. Epub 2020 Aug 24.
7
Does active smoking worsen Covid-19?主动吸烟会使新冠肺炎恶化吗？
Eur J Intern Med. 2020 Jul;77:129-131. doi: 10.1016/j.ejim.2020.05.038. Epub 2020 May 28.
8
Thank You for Not Smoking.感谢你不吸烟。
Mayo Clin Proc. 2020 Oct;95(10):2062-2064. doi: 10.1016/j.mayocp.2020.08.012.
9
Smoking amidst the COVID-19 Pandemic - the invisible threat?新冠疫情期间吸烟——无形的威胁？
Med J Malaysia. 2020 May;75(3):309-310.
10
Active smoking and severity of coronavirus disease 2019 (COVID-19): Differences in measurement of variables could cause errors in the results.主动吸烟与2019冠状病毒病（COVID-19）的严重程度：变量测量方法的差异可能导致结果出现误差。
Eur J Intern Med. 2020 Jul;77:127-128. doi: 10.1016/j.ejim.2020.05.033. Epub 2020 May 28.
引用本文的文献
1
Document analysis of the Foundation for a Smoke-Free World's scientific outputs and activities: a case study in contemporary tobacco industry agnogenesis.基金会无烟世界科学产出和活动的文献分析：当代烟草业新生的案例研究。
Tob Control. 2024 Jun 20;33(4):525-534. doi: 10.1136/tc-2022-057667.
2
The association between risk perceptions, anxiety, and self-reported changes in tobacco and nicotine product use due to COVID-19 in May-June 2020 in Israel.2020 年 5 月至 6 月期间，以色列由于 COVID-19 导致的风险认知、焦虑与自我报告的烟草和尼古丁产品使用变化之间的关联。
BMC Public Health. 2023 Apr 25;23(1):759. doi: 10.1186/s12889-023-15351-1.
3
Exploring the perceived effectiveness and cultural acceptability of COVID-19 relevant social media intervention content among Alaska Native people who Smoke: The CAN Quit study.探索吸烟的阿拉斯加原住民中与COVID-19相关的社交媒体干预内容的感知效果和文化可接受性：CAN Quit研究。
Prev Med Rep. 2022 Dec;30:102042. doi: 10.1016/j.pmedr.2022.102042. Epub 2022 Nov 7.
4
When the clock ticks wrong with COVID-19.当新冠病毒的时钟滴答作响出错时。
Clin Transl Med. 2022 Nov;12(11):e949. doi: 10.1002/ctm2.949.
5
Different death rates between COVID-19 waves among unvaccinated patients: moving beyond lessons learned.未接种疫苗患者中新冠疫情不同波次间的死亡率差异：超越经验教训
Intern Emerg Med. 2023 Jan;18(1):7-9. doi: 10.1007/s11739-022-03131-5. Epub 2022 Oct 22.
6
The association between tobacco use and COVID-19 in Qatar.卡塔尔烟草使用与新冠病毒病的关联
Prev Med Rep. 2022 Aug;28:101832. doi: 10.1016/j.pmedr.2022.101832. Epub 2022 May 19.
7
The effect of laboratory-verified smoking on SARS-CoV-2 infection: results from the Troina sero-epidemiological survey.实验室验证吸烟对 SARS-CoV-2 感染的影响：特罗伊纳血清流行病学调查结果。
Intern Emerg Med. 2022 Sep;17(6):1617-1630. doi: 10.1007/s11739-022-02975-1. Epub 2022 Apr 14.
8
Smoking Behaviors, Mental Health, and Risk Perceptions during the Beginning of the COVID-19 Pandemic among Mexican Adult Smokers.墨西哥成年烟民在新冠大流行初期的吸烟行为、心理健康和风险认知。
Int J Environ Res Public Health. 2021 Oct 17;18(20):10905. doi: 10.3390/ijerph182010905.
9
Psychotropics and COVID-19: An analysis of safety and prophylaxis.精神药物与 COVID-19：安全性与预防分析。
Encephale. 2021 Dec;47(6):564-588. doi: 10.1016/j.encep.2021.08.002. Epub 2021 Sep 2.
10
Reduced Mortality With Ondansetron Use in SARS-CoV-2-Infected Inpatients.在感染SARS-CoV-2的住院患者中使用昂丹司琼可降低死亡率。
Open Forum Infect Dis. 2021 Jul 14;8(7):ofab336. doi: 10.1093/ofid/ofab336. eCollection 2021 Jul.
本文引用的文献
1
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS.50 例 COVID-19 住院患者合并与不合并 ARDS 的特征。
Dtsch Arztebl Int. 2020 Apr 17;117(16):271-278. doi: 10.3238/arztebl.2020.0271.
2
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.纽约市 5279 例 2019 年冠状病毒病患者住院和重症的相关因素：前瞻性队列研究。
BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966.
3
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?系统评价中国住院 COVID-19 患者中当前吸烟的流行率：尼古丁是否可以成为一种治疗选择？
Intern Emerg Med. 2020 Aug;15(5):845-852. doi: 10.1007/s11739-020-02355-7. Epub 2020 May 9.
4
Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study.淋巴细胞减少症可预测新型冠状病毒肺炎的疾病严重程度：一项描述性和预测性研究。
Signal Transduct Target Ther. 2020 Mar 27;5(1):33. doi: 10.1038/s41392-020-0148-4.
5
Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.2019 年冠状病毒病患者中某些基础健康状况的初步估计——美国，2020 年 2 月 12 日至 3 月 28 日。
MMWR Morb Mortal Wkly Rep. 2020 Apr 3;69(13):382-386. doi: 10.15585/mmwr.mm6913e2.
6
Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1.比较 COVID-19 和 H1N1 导致的 ARDS 住院患者。
Chest. 2020 Jul;158(1):195-205. doi: 10.1016/j.chest.2020.03.032. Epub 2020 Mar 26.
7
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响：一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
8
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
9
Sex difference and smoking predisposition in patients with COVID-19.新型冠状病毒肺炎患者的性别差异与吸烟易感性
Lancet Respir Med. 2020 Apr;8(4):e20. doi: 10.1016/S2213-2600(20)30117-X. Epub 2020 Mar 11.
10
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
Zotero 插件